News

 

NEWS

GraphWear Technologies Raises a $4.2M Series A

GraphWear Technologies Raises a $4.2M Series A Read Full Press Release GraphWear makes a graphene-based sensor technology that can provide biological information from sweat. Initially ideated to provide performance athletes with advanced information, the latest use case in the works for GraphWear is aimed at a needle-free glucose test, expected to hit the market three to four years down the [...]Read more

Congratulations to Asilomar Bio with their success and growth to their own space in Emeryville!

Congratulations to Asilomar Bio with their success and growth to their own space in Emeryville! A field of corn is one of the most complex systems in Nature. Individual plants are constantly sensing the environment and adjusting how to use the water and nutrients in the soil. Building on breakthrough discoveries in chemistry and plant science, we are developing products [...]Read more

MBC BioLabs Grand Opening in San Carlos

MBC BioLabs Grand Opening in San Carlos In just over four years, the MBC BioLabs Dogpatch site has been home to 102 companies, 45 of which are current residents. These companies have been wildly-successful – they have raised $1.8 billion. Our one significant challenge has been the limited amount of space. We receive 6-10 applications per month, but as we [...]Read more

Wild Type raises $3.5M to reinvent meat for the 21st century

Wild Type raises $3.5M to reinvent meat for the 21st century by Danny Crichton, March 29, 2018 Read article at Techcrunch Food security is one of the grand problems facing the planet this century. The UN has estimated that food supplies need to increase by 50 percent to cover the population growth expected over the coming decades, while climate change [...]Read more

ViewPoint Therapeutics Raises $35 Million in Series B Financing

ViewPoint Therapeutics Raises $35 Million in Series B FinancingProceeds will advance lead product candidate through clinical proof-of-concept studies in cataracts and presbyopia Series B led by The Rise Fund, a global impact fund SAN FRANCISCO, Calif., March 5, 2018 – ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, [...]Read more

We welcome ph PHARMA

We welcome ph PHARMA pH Pharma’s vision is to discover and develop distinctive and innovative healthcare technologies and therapies. Our therapeutic candidates in clinical development target glaucoma and metabolic syndromes. We are also focused on a pre-clinical program to discover novel oncology therapeutics. pH Pharma was founded in 2015 and is headquartered in Seoul, South Korea with a main Silicon Valley office in [...]Read more

Enable Biosciences, Stanford, and JDRF announce $700K Research Partnership to Develop Improved Screening and Early Diagnosis Tests for Type 1 Diabetes

Enable Biosciences, Stanford, and JDRF announce $700K Research Partnership to Develop Improved Screening and Early Diagnosis Tests for Type 1 Diabetes Enable Biosciences, a UC Berkeley and Stanford-StartX diagnostics company at MBC BioLabs, and Stanford’s Division of Pediatric Endocrinology and Diabetes announce a two-year initiative to support the development of a revolutionary new technology for earlier, easier and more accurate [...]Read more

Enable Biosciences featured on KTVU for their hassle-free HIV test

MBC BioLabs company, Enable Biosciences featured on KTVU for their hassle-free HIV test BY NATHAN COLLINS Public health officials have a tough choice to make when it comes to screening people for HIV: administer a reliable blood test that can detect infections early on, but that few people will volunteer for, or give people a convenient test using saliva that [...]Read more

AbbVie and MBC BioLabs invite you to apply for the 2018 AbbVie Golden Ticket!

AbbVie and MBC BioLabs invite you to apply for the 2018 AbbVie Golden Ticket! AbbVie and MBC BioLabs invite entrepreneurial scientists and founders to apply for a 2018 AbbVie Golden Ticket. The AbbVie Golden Ticket provides a year’s use of a lab bench and core facilities at MBC BioLabs' San Francisco or San Carlos site, as well as opportunities to [...]Read more

The Bio Report with Daniel Levine

A University Spin Out that Incubates University Spin Outs The Bio Report with Daniel Levine   Listen to the interview with Douglas Crawford

Read more
Page 2 of 1212345...10...Last »

Upcoming Event

  • A Welcome Party for Newcomers! Location: 953 Indiana Street, San Francisco

    15:30-17:00
    08/31/2018
    Please join us for a celebration to welcome all new companies to the MBC BioLabs family! Come and meet the new faces in the building and enjoy some food!

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter